Drug intelligence / Profile preview

FerroFácil

Development stage
Unknown
Lead developer
Laboratório Gross
Modality
Small Molecules
Administration
Oral
01

Overview

FerroFácil is an oral dietary supplement developed and marketed by Laboratório Gross. It is formulated as a combination of liposomal ferric pyrophosphate (30 mg) and liposomal ascorbic acid (70 mg). The supplement is designed to prevent and treat iron deficiency and iron deficiency anemia. The liposomal microencapsulation technology protects the nutrients during digestion, enhancing intestinal absorption and bioavailability while minimizing common gastrointestinal side effects associated with conventional iron supplements, such as nausea, burning, and metallic taste. Ascorbic acid acts synergistically by reducing ferric iron to the more absorbable ferrous form and serving as an essential cofactor for collagen synthesis and antioxidant defense.

Brand names
FerroFácil
Other names
ascorbic acid + ferric pyrophosphateferric pyrophosphate + ascorbic acidiron + ascorbic acidiron + vitamin C
02

Targets

LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)PHD1 (Prolyl hydroxylase domain-containing protein 1)

Beyond the preview

Go deeper on FerroFácil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on FerroFácil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call